title: Design of a grid service-based platform for in silico protein-ligand screenings.
abstract: Grid computing offers the powerful alternative of sharing resources on a worldwide scale, across different institutions to run computationally intensive, scientific applications without the need for a centralized supercomputer. Much effort has been put into development of software that deploys legacy applications on a grid-based infrastructure and efficiently uses available resources. One field that can benefit greatly from the use of grid resources is that of drug discovery since molecular docking simulations are an integral part of the discovery process. In this paper, we present a scalable, reusable platform to choreograph large virtual screening experiments over a computational grid using the molecular docking simulation software DOCK. Software components are applied on multiple levels to create automated workflows consisting of input data delivery, job scheduling, status query, and collection of output to be displayed in a manageable fashion for further analysis. This was achieved using Opal OP to wrap the DOCK application as a grid service and PERL for data manipulation purposes, alleviating the requirement for extensive knowledge of grid infrastructure. With the platform in place, a screening of the ZINC 2,066,906 compound "drug-like" subset database against an enzyme's catalytic site was successfully performed using the MPI version of DOCK 5.4 on the PRAGMA grid testbed. The screening required 11.56 days laboratory time and utilized 200 processors over 7 clusters.
authors.affiliation: Department of Bioengineering, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0435, USA.
authors.forename: Marshall J
authors.initials: MJ
authors.lastname: Levesque
authors.forename: Kohei
authors.initials: K
authors.lastname: Ichikawa
authors.forename: Susumu
authors.initials: S
authors.lastname: Date
authors.forename: Jason H
authors.initials: JH
authors.lastname: Haga
mesh_terms: D001665:Binding Sites; D001699:Biometry; D003198:Computer Simulation; D016208:Databases, Factual; D055808:Drug Discovery / Q000706:statistics & numerical data*; D004353:Drug Evaluation, Preclinical / Q000706:statistics & numerical data*; D008024:Ligands; D011506:Proteins / Q000737:chemistry* / Q000378:metabolism*; D012984:Software; D014584:User-Computer Interface
chemical_list: D008024:Ligands; D011506:Proteins
references.citation: Drug Discov Today. 2002 Oct 15;7(20):1047-55
references.pmid: 12546894
references.citation: J Comput Aided Mol Des. 2006 Oct-Nov;20(10-11):601-19
references.pmid: 17149653
references.citation: J Chem Inf Model. 2006 Jan-Feb;46(1):243-53
references.pmid: 16426060
references.citation: Nature. 2004 Dec 16;432(7019):862-5
references.pmid: 15602552
references.citation: J Med Chem. 2001 Dec 6;44(25):4313-24
references.pmid: 11728179
references.citation: J Mol Biol. 2008 Mar 28;377(3):914-34
references.pmid: 18280498
references.citation: Drug Discov Today. 2002 Sep 1;7(17):903-11
references.pmid: 12546933
references.citation: J Comput Aided Mol Des. 2001 May;15(5):411-28
references.pmid: 11394736
references.citation: J Med Chem. 1999 Dec 16;42(25):5100-9
references.pmid: 10602695
references.citation: J Comput Chem. 2004 Oct;25(13):1605-12
references.pmid: 15264254
references.citation: Biochemistry. 2005 Sep 20;44(37):12316-28
references.pmid: 16156645
references.citation: J Chem Inf Model. 2005 Jan-Feb;45(1):177-82
references.pmid: 15667143
references.citation: Proteins. 1999 Nov 15;37(3):334-45
references.pmid: 10591095
references.citation: J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49
references.pmid: 11274893
references.citation: J Mol Biol. 1982 Oct 25;161(2):269-88
references.pmid: 7154081
references.citation: J Med Chem. 2002 May 23;45(11):2213-21
references.pmid: 12014959